{"name":"Asklepion Pharmaceuticals, LLC","slug":"asklepion-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Placebo of intravenous L-citrulline","genericName":"Placebo of intravenous L-citrulline","slug":"placebo-of-intravenous-l-citrulline","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Placebo of intravenous L-citrulline","genericName":"Placebo of intravenous L-citrulline","slug":"placebo-of-intravenous-l-citrulline","phase":"phase_3","mechanism":"This is a placebo control (inert substance) used in clinical trials to compare against active intravenous L-citrulline treatment.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNbGF3d3RENWw4SnZUa19YQ3plNzdfV2xHc2EyRHQ3cjY0MUo1VDJOaGxCMzBSWlRxdVluOU9yNXRzTTVRNExONFRLV0lBSW01dkJSU0JOM25tZzY1MDRkNVR5cGhXUkFzdkpDLVVkenFBaHpVRUVxcDFyNEVfd3pmOC0xUllKMjhuaktJbjgtVlB5RWIxc2hXdzZBcjZlOXZoYWdqOW04TkF5YzJpSnh3dUtoNV93UTZNNElraUtZRHI0dw?oc=5","date":"2015-03-01","type":"pipeline","source":"NZ Herald","summary":"Sanitarium to reap financial returns - NZ Herald","headline":"Sanitarium to reap financial returns","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}